Schrödinger Inc.'s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said it has entered a multi-year collaboration agreement with Swiss pharma ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

Independent global media advisor MediaSense, has acquired R3, the creative and media advisory for an undisclosed amount, to ...

Thomas also held leadership posts with Novartis, Bristol-Myers Squibb, Beigene, GSK and Amgen. Thomas received a bachelor's ...

California VC firm Aditum Bio is reaching across the Pacific to hatch a brand-new biotech. Teaming up with China ... Jimenez ...

The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and media ...

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...

Global medical companies are launching hundreds of state-of-the-art technologies in the medical product pavilion of the ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...